Repligen Dirección
Dirección controles de criterios 4/4
El CEO de Repligen's es Tony Hunt , nombrado en May 2015, tiene una permanencia de 9.08 años. compensación anual total es $7.93M, compuesta por 11.1% salario y 88.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.23% de las acciones de la empresa, por valor de $15.82M. La antigüedad media del equipo directivo y de la junta directiva es de 3.9 años y 8.3 años, respectivamente.
Información clave
Tony Hunt
Chief Executive Officer (CEO)
US$7.9m
Compensación total
| Porcentaje del salario del CEO | 11.1% |
| Permanencia del CEO | 9.2yrs |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | 4yrs |
| Promedio de permanencia en la Junta Directiva | 8.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge
Jun 14
Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?
Jun 10Repligen Stock: Still Quite Overvalued
May 30Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models
May 03Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Apr 30Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?
Feb 13Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Jan 08Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price
Dec 19What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?
Nov 01Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?
Sep 29Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade
Aug 09Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?
Jul 03With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case
Jun 19Calculating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)
May 23Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly
Apr 11Is Now An Opportune Moment To Examine Repligen Corporation (NASDAQ:RGEN)?
Mar 28We Ran A Stock Scan For Earnings Growth And Repligen (NASDAQ:RGEN) Passed With Ease
Mar 08Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Feb 20Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly
Jan 10Should You Think About Buying Repligen Corporation (NASDAQ:RGEN) Now?
Dec 28Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$15m |
| Dec 31 2023 | US$8m | US$880k | US$42m |
| Sep 30 2023 | n/a | n/a | US$116m |
| Jun 30 2023 | n/a | n/a | US$138m |
| Mar 31 2023 | n/a | n/a | US$168m |
| Dec 31 2022 | US$8m | US$800k | US$186m |
| Sep 30 2022 | n/a | n/a | US$166m |
| Jun 30 2022 | n/a | n/a | US$159m |
| Mar 31 2022 | n/a | n/a | US$146m |
| Dec 31 2021 | US$8m | US$761k | US$128m |
| Sep 30 2021 | n/a | n/a | US$119m |
| Jun 30 2021 | n/a | n/a | US$100m |
| Mar 31 2021 | n/a | n/a | US$80m |
| Dec 31 2020 | US$5m | US$725k | US$60m |
| Sep 30 2020 | n/a | n/a | US$44m |
| Jun 30 2020 | n/a | n/a | US$31m |
| Mar 31 2020 | n/a | n/a | US$23m |
| Dec 31 2019 | US$4m | US$685k | US$21m |
| Sep 30 2019 | n/a | n/a | US$23m |
| Jun 30 2019 | n/a | n/a | US$27m |
| Mar 31 2019 | n/a | n/a | US$21m |
| Dec 31 2018 | US$14m | US$600k | US$17m |
| Sep 30 2018 | n/a | n/a | US$23m |
| Jun 30 2018 | n/a | n/a | US$23m |
| Mar 31 2018 | n/a | n/a | US$29m |
| Dec 31 2017 | US$3m | US$550k | US$28m |
Compensación vs. Mercado: La compensación total ($USD7.93M) de Tony está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD8.45M).
Compensación vs. Ingresos: La compensación de Tony ha sido consistente con los resultados de la empresa en el último año.
CEO
Tony Hunt (60 yo)
9.2yrs
Permanencia
US$7,929,275
Compensación
Mr. Anthony J. Hunt, also known as Tony, serves as Director at 908 Devices Inc. since March 2, 2022. He has been the Chief Executive Officer of Repligen Corporation since May 21, 2015 and served as its Pre...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 9.2yrs | US$7.93m | 0.23% $ 15.3m | |
| President & Chief Commercial Officer | less than a year | US$5.45m | sin datos | |
| CFO & Chief Compliance Officer | less than a year | US$2.03m | sin datos | |
| Chief Operating Officer | 4.3yrs | US$3.74m | 0.037% $ 2.5m | |
| Senior Vice President of Filtration & Chromatography | 4yrs | US$1.66m | 0.049% $ 3.3m | |
| Senior Vice President of Research & Development | 7.8yrs | US$1.66m | 0.031% $ 2.1m | |
| Chief Information Officer | no data | sin datos | sin datos | |
| Global Head of Investor Relations | no data | sin datos | sin datos | |
| General Counsel & Global Head of Legal | no data | sin datos | sin datos | |
| VP & Global Head of Sales | 1.8yrs | sin datos | sin datos | |
| Vice President of Human Resources | 1.5yrs | sin datos | sin datos | |
| Senior VP of Strategy and Business Development & Global Head of Bioprocess Analytics | 4.5yrs | sin datos | sin datos |
4.0yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de RGEN se considera experimentado (3.9 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 9.2yrs | US$7.93m | 0.23% $ 15.3m | |
| Independent Director | 8.8yrs | US$322.84k | 0.014% $ 910.5k | |
| Member of Scientific Advisory Board | 8.3yrs | sin datos | sin datos | |
| Independent Director | 1.4yrs | US$453.50k | 0.0070% $ 471.0k | |
| Independent Chairperson of the Board | 18.8yrs | US$431.12k | 0.16% $ 10.5m | |
| Independent Director | 4.1yrs | US$287.84k | 0.0050% $ 335.5k | |
| Member of Scientific Advisory Board | 8.3yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board & Independent Director | 8.3yrs | US$282.84k | 0.00096% $ 64.4k | |
| Member of Scientific Advisory Board | 8.3yrs | sin datos | sin datos | |
| Independent Director | 4.3yrs | US$287.84k | 0.0042% $ 281.8k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 10.1yrs | US$307.84k | 0.0071% $ 476.4k |
8.3yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de RGEN se considera experimentada (8.3 años de antigüedad promedio).